NANCY HINDALONG: Open Payments
NPI 1164075560 · LECANTO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,422 in 51 payments from 16 companies in 2025. Trend: 2023 $1,886 · 2024 $1,925 · 2025 $1,422
Food & beverage: $1,242Education: $180
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 6 | $276 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $272 |
| Janssen Biotech, Inc. | 4 | $169 |
| ABBVIE INC. | 9 | $152 |
| UCB, Inc. | 3 | $99 |
| Hill Dermaceuticals, Inc. | 1 | $80 |
| PFIZER INC. | 3 | $64 |
| GENZYME CORPORATION | 2 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| Lilly USA, LLC | 2 | $49 |
Products named: DUPIXENT, ILUMYA, TREMFYA, SKYRIZI, Bimzelx, Tolak, CIBINQO, COSENTYX.
Industry payments across FL — which companies pay providers there.
